1-3 of 3
Sorina Nicoleta Badelita
Close
Sort by
Journal Articles

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)

Efstathios Kastritis, Meral Beksac, Sorina Nicoleta Badelita, Eirini Katodritou, Jelena Bila, Emmanouil Spanoudakis, Guldane Cengiz Seval, Zorica Cvetkovic, Olivera Markovic, Selami Kocak Toprak, Dimitra Dalampira, Daniel Coriu, Zoi Bezirgiannidou, Mario Pirsic, Toni Valkovic, Iulia Ursuleac, Aleksandra Sretenovic, Angeliki Sevastoudi, Josip Batinic, Sinziana Barbu, Maria Roussou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood
Blood (2023) 142 (Supplement 1): 4734.
https://doi.org/10.1182/blood-2023-179416
Published: 2023
Journal Articles

Real-World Evidence of the Use of Carfilzomib Among Multiple Myeloma Patients with at Least One Prior Therapy across 10 European Countries and Israel

Evangelos Terpos, MDPhD, Borhane Slama, MD, Renato Zambello, Sorina Nicoleta Badelita, MD, Eirini Katodritou, MD, Jo Caers, MD PhD, Thomas Kühr, MD, Florence Suzan, MD, Abeera Mohammad, MSc, Sally Wetten, MSc, Xavier Leleu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-134475
Published: 2020
Journal Articles

Real-World Evidence of the Use of Approved Carfilzomib Regimens in Patients Previously Exposed or Refractory to Lenalidomide: Updated Results from a Prospective Observational Study

Xavier Leleu, MD, Borhane Slama, MD, Renato Zambello, Sorina Nicoleta Badelita, MD, Eirini Katodritou, MD, Jo Caers, MD PhD, Thomas Kühr, MD, Florence Suzan, MD, Abeera Mohammad, MSc, Sally Wetten, MSc, Evangelos Terpos, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-134476
Published: 2020